therapy for MPN patients

March 9, 2018
MPN cells

Ruxolitinib Metformin combo: A Possible Alternative Treatment for Myeloproliferative Neoplasm Patients

Metformin demonstrates antileukemic activity and may have clinical implications for the treatment of myeloproliferative neoplasms (MPN) in combination with ruxolitinib, according to a study published in Cell Death & […]
Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security